Literature DB >> 23486303

Effectiveness of high-frequency transcutaneous electrical nerve stimulation at tender points as adjuvant therapy for patients with fibromyalgia.

F Carbonario1, L A Matsutani, S L K Yuan, A P Marques.   

Abstract

BACKGROUND: Fibromyalgia is a chronic pain syndrome associated with sleep disorders, fatigue and psychological symptoms. Combinations therapies, such as electrotherapy and therapeutic exercises have been used in the clinical practice. AIM: To assess the efficacy of high-frequency transcutaneous electrical nerve stimulation (TENS) as an adjuvant therapy to aerobic and stretching exercises, for the treatment of fibromyalgia.
DESIGN: Controlled clinical trial.
SETTING: Unit of rehabilitation of a public hospital. POPULATION: Twenty-eight women aged 52.4±7.5 years, with fibromyalgia.
METHODS: A visual analogue scale measured pain intensity; tender points pain threshold, by dolorimetry; and quality of life, by the Fibromyalgia Impact Questionnaire. All subjects participated in an eight-week program consisting of aerobic exercises, followed by static stretching of muscle chains. In TENS group, high-frequency (150 Hz) was applied on bilateral tender points of trapezium and supraspinatus.
RESULTS: TENS group had a greater pain reduction (mean change score=-2.0±2.9 cm) compared to Without TENS group (-0.7±3.7 cm). There was a difference between mean change scores of each group for pain threshold (right trapezium: 0.2±1 kg/cm² in TENS group and -0.2±1.2 kg/cm² in Without TENS group). In the evaluation of clinically important changes, patients receiving TENS had relevant improvement of pain, work performance, fatigue, stiffness, anxiety and depression compared to those not receiving TENS.
CONCLUSION: It has suggested that high-frequency TENS as an adjuvant therapy is effective in relieving pain, anxiety, fatigue, stiffness, and in improving ability to work of patients with fibromyalgia. CLINICAL REHABILITATION IMPACT: High-frequency TENS may be used as a short-term complementary treatment of fibromyalgia.

Entities:  

Mesh:

Year:  2013        PMID: 23486303

Source DB:  PubMed          Journal:  Eur J Phys Rehabil Med        ISSN: 1973-9087            Impact factor:   2.874


  17 in total

Review 1.  Using TENS for pain control: the state of the evidence.

Authors:  Carol G T Vance; Dana L Dailey; Barbara A Rakel; Kathleen A Sluka
Journal:  Pain Manag       Date:  2014-05

2.  Wireless transcutaneous electrical nerve stimulation device for chemotherapy-induced peripheral neuropathy: an open-label feasibility study.

Authors:  Jennifer S Gewandter; Jenna Chaudari; Chinazom Ibegbu; Rachel Kitt; Jennifer Serventi; Joy Burke; Eva Culakova; Noah Kolb; Kathleen A Sluka; Mohamedtaki A Tejani; Nimish A Mohile
Journal:  Support Care Cancer       Date:  2018-08-27       Impact factor: 3.603

3.  Differential efficiency of transcutaneous electrical nerve stimulation in dominant versus nondominant hands in fibromyalgia: placebo-controlled functional near-infrared spectroscopy study.

Authors:  Aykut Eken; Murat Kara; Bora Baskak; Ayşegül Baltacı; Didem Gökçay
Journal:  Neurophotonics       Date:  2017-09-05       Impact factor: 3.593

Review 4.  Characterising the Features of 381 Clinical Studies Evaluating Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Relief: A Secondary Analysis of the Meta-TENS Study to Improve Future Research.

Authors:  Mark I Johnson; Carole A Paley; Priscilla G Wittkopf; Matthew R Mulvey; Gareth Jones
Journal:  Medicina (Kaunas)       Date:  2022-06-14       Impact factor: 2.948

Review 5.  Transcutaneous electrical nerve stimulation (TENS) for fibromyalgia in adults.

Authors:  Mark I Johnson; Leica S Claydon; G Peter Herbison; Gareth Jones; Carole A Paley
Journal:  Cochrane Database Syst Rev       Date:  2017-10-09

Review 6.  Electrode Materials for Chronic Electrical Microstimulation.

Authors:  Xin Sally Zheng; Chao Tan; Elisa Castagnola; Xinyan Tracy Cui
Journal:  Adv Healthc Mater       Date:  2021-05-24       Impact factor: 11.092

7.  Reduction in movement-evoked pain and fatigue during initial 30-minute transcutaneous electrical nerve stimulation treatment predicts transcutaneous electrical nerve stimulation responders in women with fibromyalgia.

Authors:  Carol G T Vance; M Bridget Zimmerman; Dana L Dailey; Barbara A Rakel; Katharine M Geasland; Ruth L Chimenti; Jon M Williams; Meenakshi Golchha; Leslie J Crofford; Kathleen A Sluka
Journal:  Pain       Date:  2021-05-01       Impact factor: 7.926

8.  Application of low frequency and medium frequency currents in the management of acute and chronic pain-a narrative review.

Authors:  Stephen Rajan Samuel; G Arun Maiya
Journal:  Indian J Palliat Care       Date:  2015 Jan-Apr

9.  The Effects of High-Frequency Transcutaneous Electrical Nerve Stimulation for Dental Professionals with Work-Related Musculoskeletal Disorders: A Single-Blind Randomized Placebo-Controlled Trial.

Authors:  Hye Rim Suh; Tae Hoon Kim; Gyeong-Soon Han
Journal:  Evid Based Complement Alternat Med       Date:  2015-11-17       Impact factor: 2.629

Review 10.  Beyond pain in fibromyalgia: insights into the symptom of fatigue.

Authors:  Ann Vincent; Roberto P Benzo; Mary O Whipple; Samantha J McAllister; Patricia J Erwin; Leorey N Saligan
Journal:  Arthritis Res Ther       Date:  2013       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.